Analgesic Effect Between TAP Block and Continuous Wound Infusion in Abdominoplasty Surgery
Launched by UNIVERSITY OF LIEGE · May 21, 2013
Trial Information
Current as of April 28, 2025
Unknown status
Keywords
ClinConnect Summary
In a first group, patients receive, after induction of anaesthesia and before surgery, a TAP block (transverse abdominal plan block) with 3mg/kg Ropivacaine 0.5% (maximum 200 mg) and 150 microg Clonidine.
In a second group, before skin closure, a multiholes catheter was inserted beyond the skin. 20 mg Ropivacaine 0.2% added with 150 microg Clonidine was injected as bolus dose through this catheter followed by a continuous infusion of Ropivacaine 0.2% 10ml per hour during the following 9 hours (total dose of 200 mgr).
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for abdominoplasty combined with flank liposuction
- Exclusion Criteria:
- • Allergy to local anesthetics or clonidine
- • Coagulation disorders
- • History of chronic pain
- • Alcohol or drugs dependance
- • Refusal of the patients
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liege, , Belgium
Patients applied
Trial Officials
Jean-Pierre H Lecoq, Md, PhD
Principal Investigator
University of Liege, University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials